Overview


According to FutureWise analysis the market for lumbar disc herniation treatment in 2023 is US$ 2.83 million, and is expected to reach US$ 4.65 million by 2031 at a CAGR of 6.42%.

Lumbar disc herniation (LDH), is a common low back ailment. It's one of the most common conditions that causes patients to have low back or leg pain. When disc material (nucleus pulposus or annulus fibrosis) is moved outside the intervertebral disk's region, it is called a herniated disc. The failure of the innermost annulus rings starts the herniation cycle, which progresses radially outward. The annulus of the disc is typically damaged when the spine is completely flexed for a lengthy period of time. Intervertebral degeneration, which leads to degenerative disc disease and lumbar disc herniation, is the most common cause of Lower back pain. Low back pain and radicular limb discomfort are frequently caused by lumbar disc herniation, which most commonly affects the L4-L5 and L5-S1 levels. Number of people smoking have increased, Smoking is thought to restrict oxygen flow to discs, causing them to break down more quickly. People's sedentary lifestyles,is another reasons for providing boost to the market. Additionally, increased investment in advanced technology research and an increase in the number of emerging markets will give further provide growth opportunities for the lumbar disc herniation treatment market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Lumbar Disc Herniation Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Lumbar Disc Herniation Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Boehringer Ingelheim International GmbH.
  • AstraZeneca
  • Johnson and Johnson Private Limited
  • MerckCo., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Zydus Cadila
  • NuVasive, Inc.
  • Globus Medical
  • Zimmer Biomet
  • Medtronic
  • Stryker
  • Assertio Therapeutics, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Location Type

  • Axillary
  • Foraminal
  • Posterolateral
  • Central Prolapse

By Diagnosis

  • Nerve Tests
  • Electromyography (EMG)
  • Nerve conduction study
  • Imaging Tests
  • Magnetic resonance imaging (MRI)
  • Myelogram
  • Computerized tomography (CT) scan
  • X-rays
  • Others

By Treatment

  • Medication
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Opioids
  • Muscle relaxers
  • Local corticosteroid injections (CSI)
  • Surgery
  • Far lateral microdiskectomy
  • Laminotomy and discectomy
  • Physical Therapy
  • Others

By Type

  • Chronic
  • Acute

By Dosage Form

  • Injection
  • Tablets
  • Others

By Route of Administration

  • Parenteral
  • Oral
  • Others

By End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Lumbar Disc Herniation Treatment Market By Location Type, By Diagnosis, By Treatment, By Type, By Dosage Form, By Route of Administration, By End-Users, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Lumbar Disc Herniation Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Lumbar Disc Herniation Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Lumbar Disc Herniation Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Lumbar Disc Herniation Treatment Market, By Location Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Axillary
        2. Foraminal
        3. Posterolateral
        4. Central Prolapse

  • 8.   Lumbar Disc Herniation Treatment Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Nerve Tests
        2. Electromyography (EMG)
        3. Nerve conduction study
        4. Imaging Tests
        5. Magnetic resonance imaging (MRI)
        6. Myelogram
        7. Computerized tomography (CT) scan
        8. X-rays
        9. Others

  • 9.   Lumbar Disc Herniation Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medication
        2. Non-steroidal anti-inflammatory drugs (NSAIDs)
        3. Opioids
        4. Muscle relaxers
        5. Local corticosteroid injections (CSI)
        6. Surgery
        7. Far lateral microdiskectomy
        8. Laminotomy and discectomy
        9. Physical Therapy
        10. Others

  • 10.   Lumbar Disc Herniation Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chronic
        2. Acute

  • 11.   Lumbar Disc Herniation Treatment Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Injection
        2. Tablets
        3. Others

  • 12.   Lumbar Disc Herniation Treatment Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Parenteral
        2. Oral
        3. Others

  • 13.   Lumbar Disc Herniation Treatment Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others

  • 14.   Lumbar Disc Herniation Treatment Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
        4. Others

  • 15.   North America Lumbar Disc Herniation Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 16.   Latin America Lumbar Disc Herniation Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 17.   Europe Lumbar Disc Herniation Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 18.   Asia Pacific Lumbar Disc Herniation Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 19.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 20.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 21.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GlaxoSmithKline plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Novartis AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Teva Pharmaceutical Industries Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Boehringer Ingelheim International GmbH.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AstraZeneca
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Johnson & Johnson Private Limited
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. MerckCo., Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. F. Hoffmann-La Roche Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sun Pharmaceutical Industries Ltd.
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
         12. Aurobindo Pharma
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. Zydus Cadila
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
        14. NuVasive, Inc.
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
         15. Globus Medical
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
         16. Zimmer Biomet
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
         17. Medtronic
          17.1. Company Overview
          17.2. Product Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
         18. Stryker
          18.1. Company Overview
          18.2. Product Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
         19. Assertio Therapeutics, Inc.
          19.1. Company Overview
          19.2. Product Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview

  • 22.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 23.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients